Home Compare BMY vs PNR
Stock Comparison · Structural lead, mixed market

Bristol-Myers Squibb Company vs Pentair: Which Stock Looks Stronger in 2026?

The structural profiles are close, with Bristol-Myers Squibb Company carrying a narrow edge on growth. Pentair still has the edge on profitability, which keeps the comparison from looking entirely one-sided. The market setup broadly confirms the structural lead — Bristol-Myers Squibb Company holds the more constructive position. That puts structure and market broadly in agreement — Bristol-Myers Squibb Company's lead looks more confirmed than conflicted.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The clearest separation starts in growth, but stability adds another real layer to the result.

Trajectory Similarity
0.68
Moderately similar
Peer-set rank: #8
within Bristol-Myers Squibb Company's functional peer set

This pair is matched through long-term financial trajectory similarity within the selected peer universe.

A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.

Most of the shared profile comes through investment intensity and revenue growth trajectory.

Similarity drivers
investment intensityrevenue growth trajectory
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
BMY
Bristol-Myers Squibb Company
61
Peer-Score
Signal qualityHigh
vs
PNR
Pentair plc
56
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: BMY vs PNR Profitability 38 60 Stability 56 37 Valuation 86 81 Growth 62 33 BMY PNR
Gap Ranking
#1 Growth +29
#2 Profitability +22
#3 Stability +19
#4 Valuation +5
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for BMY and PNR Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer BMYPNR Relative valuation Structural strength

Bristol-Myers Squibb Company still looks stronger, and the price setup does not materially undermine that lead.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
On growth, Bristol-Myers Squibb Company is positioned higher in the group, while Pentair plc is closer to the middle.
Profitability
On profitability, Pentair plc is positioned higher in the group, while Bristol-Myers Squibb Company is closer to the middle.
Growth — Dominant Gap
BMY
62
PNR
33
Gap+29in favour of BMY

Earnings growth is one contributing factor within the growth lead.

What keeps the gap from being one-sided

There is still a strong counterforce in profitability, so the lead stays clear without becoming a sweep.

What this means for the comparison

Growth points more clearly to Bristol-Myers Squibb Company, but profitability still runs the other way — keeping the broader result from looking fully settled.

Explore full peer positioning in AssetNext

Break down the BMY vs PNR comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how BMY and PNR each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.